aetherAI vs Freenome

aetherAI Endo is a colon polyp detection module that its About page dates to 2021, and openFDA carries no FDA number for it. It belongs in a pathology lab. Freenome's SimpleScreen CRC works earlier in colorectal care. FDA approved it under PMA P250029 in July 2026 as a blood test for colorectal cancer screening in adults 45 and older at average risk, and a positive result is followed by colonoscopy. The clinician ordering that screening is the buyer, though the approval release names no ordering route or price and says Abbott will commercialize the test exclusively in the US. In the PREEMPT CRC trial of more than 48,000 average-risk adults, the vendor reports 81.1% sensitivity for colorectal cancer, 13.7% for advanced precancerous lesions and 90.4% specificity for advanced colorectal neoplasia.